DEIANA, Giovanni Andrea
 Distribuzione geografica
Continente #
NA - Nord America 2.270
EU - Europa 1.698
AS - Asia 915
OC - Oceania 10
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 4.907
Nazione #
US - Stati Uniti d'America 2.260
UA - Ucraina 581
CN - Cina 560
SG - Singapore 304
SE - Svezia 294
FR - Francia 280
DE - Germania 235
IT - Italia 105
FI - Finlandia 89
GB - Regno Unito 45
BE - Belgio 20
KR - Corea 15
TR - Turchia 12
CA - Canada 9
CZ - Repubblica Ceca 9
AU - Australia 7
AT - Austria 5
IN - India 5
NL - Olanda 5
EU - Europa 4
GR - Grecia 4
IR - Iran 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
BR - Brasile 3
CL - Cile 3
ES - Italia 3
HR - Croazia 3
NZ - Nuova Zelanda 3
PL - Polonia 3
RO - Romania 3
CH - Svizzera 2
IE - Irlanda 2
IL - Israele 2
JP - Giappone 2
ZA - Sudafrica 2
AM - Armenia 1
AZ - Azerbaigian 1
EC - Ecuador 1
EE - Estonia 1
HK - Hong Kong 1
HU - Ungheria 1
KZ - Kazakistan 1
ME - Montenegro 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
Totale 4.907
Città #
Chandler 537
Jacksonville 371
Singapore 241
Princeton 185
Dearborn 162
Nanjing 152
Wilmington 93
Nanchang 69
Ann Arbor 60
New York 59
Boardman 58
Beijing 52
Hebei 40
Shenyang 38
Woodbridge 36
Tianjin 34
Changsha 33
Ashburn 31
Jiaxing 26
Sassari 23
Rome 21
Brussels 20
Jinan 17
Munich 16
Bochum 15
Seoul 15
Andover 14
Hangzhou 13
Santa Clara 13
Kunming 11
Izmir 10
Zhengzhou 10
Guangzhou 9
Norwalk 9
Ningbo 8
San Francisco 8
Brno 7
Los Angeles 7
Taizhou 6
Auburn Hills 5
Changchun 5
Mountain View 5
Shanghai 5
Toronto 5
Amsterdam 4
Hanover 4
Lanzhou 4
Pátrai 4
Vienna 4
Gelsenkirchen 3
London 3
Melbourne 3
Monmouth Junction 3
Oristano 3
Paris 3
Phoenix 3
San Mateo 3
Vélizy 3
Washington 3
Zagreb 3
Alghero 2
Arcata 2
Ardabil 2
Cagliari 2
Canberra 2
Charlotte 2
Dallas 2
Dubai 2
Dublin 2
Edinburgh 2
Fairfield 2
Frankfurt am Main 2
Fuzhou 2
Gioia Del Colle 2
Haikou 2
Houston 2
Johannesburg 2
Leawood 2
Madrid 2
Markham 2
Montreal 2
Münster 2
Olomouc 2
Preston 2
Rio Saliceto 2
Romola 2
Sydney 2
Tokyo 2
Warsaw 2
Almaty 1
Almere Stad 1
Auckland 1
Augusta 1
Baku 1
Bangkok 1
Belgrade 1
Bristol 1
Campinas 1
Chengdu 1
Chicago 1
Totale 2.676
Nome #
Expressive aphasia exacerbated by lamotrigine and gabapentin 80
Herv-k modulates the immune response in als patients 79
Determination of L-alpha aminoadipic acid levels in human and experimental epilepsy 78
A liquid chromatography-mass spectrometry study on the spirocyclization of ninhydrin with the aminothiols 74
Asterixis and mild encephalopathy induced by gabapentin 73
"Erratic" complex partial status epilepticus as a presenting feature of MELAS 72
Hyperthermia, choreic dyskinesias and increased motor tone in Wernicke's encephalopathy 72
Intravenous glutathione in patients with Parkinson's disease 71
Brain intgerstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 69
A simple capillary electrophoresis method for the analysis of lamotrigine in serum 67
Neuroleptic maglignant syndrome and related syndromes in a neurological popupation 65
Detection of Chlamydia Pneumoniae In the CSF of Sardinian Patients With Multiple Sclerosis In The Presence Or Absence Of Oligoclonal Bands 64
Delayedonset cerebellar tremors (DOCT): natural history and treatment 64
Acute hyponatremia and neuroleptic malignant syndrome 63
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 63
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 63
Carbamazepine, clonazepam and focal reflex proprioceptives seizures 62
Carbamazepine therapy for steroid psychosis 62
Levetiracetam in stiff-person syndrome 62
Cerebral and cerebellar diaschisis following carbamazepine therapy 61
Brain interstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 60
Epilepsy in multiple sclerosis: Does AED resistances predict a worse outcome of disability? 59
Open study of the activity and tolerability of reduced intravenous glutathione in Parkinson's disease 59
Reduced intravenous glutathione in the treatment of early Parkinson's disease 58
MuSK antibody-positive, seronegative myasthenia gravis in two sisters 57
Tache Noire in a Patient with Acute Q Fever 57
Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia 56
Neuroleptic malignant syndrome and sudden death after combined zuclopenthixol/trihexiphenidyl withdrawal 56
Siti di tremore "rubrale" 56
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 56
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 56
Ceruloplasmin and oxidative stress in multiple sclerosis 55
Complex partial status epilepticus as presenting features of MELAS: Case report and review of literature 55
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 55
Brain interstitial fluid collected trhough implanted tissue cages 55
Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up 55
Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls 54
Chronic parkinsonism after use of diquat: clinical and MRI studies 54
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson's disease 53
Carbamazepine, clonazepam and focal reflex proprioceptive seizures 53
Post-ischemic cerebellar tremors and axonal sprouting in humans 53
Excitatory amino acids in brain interstitial fluid during sustained pentylenetetrazole-induced seizures 53
Reduced intravenous glutathione in Parkinson's disease 53
Beneficial effect of risperidone on behavioral disturbances associated with hyperostosis frontalis interna 52
Delayed-onset cerebellar tremor after stroke 52
Attività epilettogena del tiocolchicoside nell'uomo e nel ratto wistar 52
Cytokines and multiple sclerosis severity: no correlation among Sardinians 52
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 52
Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies 52
Focal e secondarily generalized convulsive status epilepticus induced by thiocolchicoside in the rat 52
Increase of alpha-aminoadipate in brain IF during PTZ-induced status epilepticus 51
Carbamazepine in delayed-onset cerebellar tremor 51
Preliminary experience with fluoxetine in primary focal dystonias 50
Beneficial effect of fluoxetine in hyperekplexia 50
Focal and secondarily generalised convulsive status epilepticus induced by thiocolchicoside in the rat 50
Non-fluent speech in patients with partial epilepsy: Beneficial effect of levetiracetam 49
Pharmacology of delayed-onset cerebellar tremors 49
Carbamazepine in delayed-onset cerebellar tremor 49
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazole-induced convulsive status epilepticus 49
Reduced intravenous glutathione in the treatment of early Parkinson’s Disease 48
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 48
In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation 47
Risperidone, neuroleptic malignant sindrome and probable dementia with Lewy bodies 47
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 47
Brain interstitial fluid collected through implanted tissue cages 47
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 47
Cerebrospinal fluid gamma-glutamyl transpeptidase in multiple sclerosis 47
Successful screening for Fabry disease in patients with juvenile stroke in North Sardinia 47
Non – fluent spech in patients with partial epilepsy: beneficial effect of levetiracetam 47
Discinesie bucco-linguali indotte dal fenobarbitale 46
Neuroleptic maglignant syndrome and related syndromes in a neurological population 46
Diaschisis, "Rossi -Effect", and antiepileptic action of carbamazepine 46
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson’s Disease 45
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 44
Encephalopathies related to antiepileptic drugs 43
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazol-induced convulsive status epilepticus 43
Epilepsy in multiple sclerosis: does predict a worse outcome of disability? 43
Urine bikunin as a marker of renal impairment in Fabry's disease 40
Neurological disorders associated with Mycoplasma pneumoniae infection 40
Complex partial status epilepticus as presenting feature of MELAS: case report and rewiew of literature 40
Effetti avversi psichiatrici da steroidi e carbamazepina 40
Intrathecal overproduction of ceruloplasmin in patients with multiple sclerosis 38
Familial autoimmune MuSK positive myasthenia gravis 37
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 36
Epileptogenic activity of thiocolchicoside 36
Ceftriaxone has a therapeutic role in Alexander disease 36
Glycosaminoglycans and fabry’s disease 35
Ictus giovanile e Malattia di Fabry: lo stato dell’arte in Sardegna 35
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 33
Multiple sclerosis: correlation between cytokine production and disease progression in Sardinians 32
Status epileptics induced by administration of thiocolchicoside to lithium-pretreated rats 30
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 30
null 28
Topiramate in patients with cerebellar tremor: a controlled trial 28
Pharmacology of delayed-onset cerebellar tremors 26
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 20
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges 18
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 16
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 15
Neuroimaging leads to recognition of previously undiagnosed Fabry 4
Totale 4.975
Categoria #
all - tutte 23.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020755 0 0 0 0 101 149 184 34 114 71 100 2
2020/2021920 98 0 160 8 95 66 98 3 150 146 54 42
2021/2022455 95 12 2 19 3 0 21 31 43 17 52 160
2022/20231.070 99 58 9 176 128 196 0 115 194 12 51 32
2023/2024320 54 41 10 8 80 21 2 20 9 7 26 42
2024/2025450 71 13 177 55 134 0 0 0 0 0 0 0
Totale 4.975